Allarity Therapeutics (ALLR) Current Taxes (2020 - 2026)
Allarity Therapeutics' (ALLR) quarterly Current Taxes came in at $81000.0 in Q1 2026, up 6.58% YoY from $76000.0 in Q1 2025, and little changed on a QoQ basis from $81000.0 in Q4 2025.
Allarity Therapeutics (ALLR) Current Taxes (2020 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 7 years of Current Taxes data on file, last reported at $81000.0 in Q1 2026.
- Quarterly Current Taxes rose 6.58% year-over-year to $81000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $81000.0 (up 6.58% YoY) and the FY2025 annual result came in at $81000.0, up 9.46% from the prior year.
- Current Taxes held at $81000.0 in Q1 2026, from $81000.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $83000.0 in Q3 2022 to a low of $23000.0 in Q2 2022.
- A 5-year average of $58352.9 and a median of $59000.0 in 2023 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2023 — Current Taxes sank 66.27% — and 2024, when it surged 114.29%.
- Tracing ALLR's Current Taxes over 5 years: stood at $41000.0 in 2022, then soared by 43.9% to $59000.0 in 2023, then gained by 25.42% to $74000.0 in 2024, then grew by 9.46% to $81000.0 in 2025, then changed by 0.0% to $81000.0 in 2026.
- The last three Current Taxes figures came in at $81000.0 (Q1 2026), $81000.0 (Q4 2025), and $81000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - | 81,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81,000.00 |
| Dec 31, 2025 | 81,000.00 |
| Sep 30, 2025 | 81,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Mar 31, 2025 | 76,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Sep 30, 2024 | 60,000.00 |
| Jun 30, 2024 | 57,000.00 |
| Mar 31, 2024 | 43,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Sep 30, 2023 | 28,000.00 |
| Jun 30, 2023 | 36,000.00 |
| Mar 31, 2023 | 36,000.00 |
| Dec 31, 2022 | 41,000.00 |
| Sep 30, 2022 | 83,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Mar 31, 2022 | 52,000.00 |
| Dec 31, 2021 | 60,000.00 |
| Sep 30, 2021 | 54,000.00 |
| Dec 31, 2020 | 57,000.00 |